Published in Gene Therapy Weekly, May 5th, 1997
p53 gene mutations are found in 30 percent of in situ lung cancers and in 60 percent of invasive lung cancers. Yiyu Zou and colleagues from the University of Texas, M.D. Anderson Cancer Center in Houston, Texas, chose p53 gene replacement to test the feasibility of lipid-based gene delivery systems for local regional therapy of the respiratory tract. They presented results from in vitro and in vivo experiments at the American Association for Cancer Research conference, held April 12-16, 1997, in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.